ScholarIQanswers from OpenAlex

Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy

PaperCitations, authors & open-access status

Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy have?

ScholarIQcitation count

Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy has 274 citations in the OpenAlex counts ScholarIQ stores.

When was Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy published?

ScholarIQyear

Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy has 2012 year in the ScholarIQ index.

What is the open-access status of Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy?

ScholarIQoa status

Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy has closed oa status in the ScholarIQ index.

What is the DOI of Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy?

ScholarIQdoi

The DOI for Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy is on the source record.

What is the PMID of Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy?

ScholarIQpmid

The PMID for Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy is on the source record.

What is the OpenAlex record for Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy?

ScholarIQopenalex

The OpenAlex for Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial